Characterization of the mechanism of action of lanraplenib, a novel spleen tyrosine kinase inhibitor, in models of lupus nephritis

Overview of attention for article published in BMC Rheumatology, March 2021

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 2 X users

facebook: 1 Facebook page

Citations

dimensions_citation: 6 Dimensions

Readers on

mendeley: 13 Mendeley

Summary X Facebook Dimensions citations

So far, Altmetric has seen 1 public wall post.

Drgios world, 24 Feb 2022

Background B cells are critical mediators of systemic lupus erythematosus (SLE) and lupus nephritis (LN), and antinuclear…

This page shows the most recent Facebook posts that mention this research output.

Click here to find out how to access more activity.